NeuroPace (NPCE) Asset Writedowns and Impairment (2020 - 2026)
NeuroPace (NPCE) posted quarterly Asset Writedowns and Impairment of $76000.0 for Q1 2026, up 72.73% year-over-year from $44000.0 in Q1 2025, and up 26.67% quarter-over-quarter from $60000.0 in Q4 2025.
NeuroPace (NPCE) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
NeuroPace's Asset Writedowns and Impairment history runs 7 years deep, the most recent figure standing at $76000.0 for Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment rose 72.73% year-over-year to $76000.0; the TTM figure through Mar 2026 stood at $232000.0 (down 21.89% YoY), while the FY2025 annual figure was $200000.0, down 33.33% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $76000.0, up from $60000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $107000.0 in Q3 2024, with the low at $34000.0 in Q1 2023.
- The 5-year median for Asset Writedowns and Impairment is $49000.0 (2025), against an average of $59705.9.
- The sharpest annual moves came in 2022 and 2023: Asset Writedowns and Impairment surged 241.67% in 2022, then tumbled 58.54% in 2023.
- NeuroPace's Asset Writedowns and Impairment stood at $39000.0 in 2022, then surged by 64.1% to $64000.0 in 2023, then jumped by 62.5% to $104000.0 in 2024, then sank by 42.31% to $60000.0 in 2025, then increased by 26.67% to $76000.0 in 2026.
- Business Quant data shows NPCE's Asset Writedowns and Impairment at $76000.0 in Q1 2026, $60000.0 in Q4 2025, and $47000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | NeuroPace | 479.51 Mn | 427.81 Mn | 18.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 68,000.00 |
| Jun 30, 2026 | 68,000.00 |
| Mar 31, 2026 | 76,000.00 |
| Mar 31, 2026 | 76,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Dec 31, 2024 | 104,000.00 |
| Dec 31, 2024 | 104,000.00 |
| Sep 30, 2024 | 107,000.00 |
| Sep 30, 2024 | 107,000.00 |
| Jun 30, 2024 | 42,000.00 |
| Jun 30, 2024 | 42,000.00 |
| Mar 31, 2024 | 47,000.00 |
| Mar 31, 2024 | 47,000.00 |